In a first, US scientists have engineered an artificial ribosome - the protein synthesisers of the cell - or what the scientists call 'protein-making factory' that may enable the production of new drugs and next-generation biomaterial.
The artificial ribosome, called Ribo-T, works nearly as well as the authentic cellular component that produces all the proteins and enzymes within the cell, the study said.
Not only did Ribo-T make proteins in a test-tube, it was able to make enough protein in bacterial cells that lacked natural ribosomes to keep the bacteria alive.
"Our new protein-making factory holds promise to expand the genetic code in a unique and transformative way, providing exciting opportunities for synthetic biology and biomolecular engineering," said one of the researchers Michael Jewett, assistant professor of chemical and biological engineering at Northwestern University in the US.
The scientists believe that Ribo-T would lead to a better understanding of how ribosomes function.
"This is an exciting tool to explore ribosomal functions by experimenting with the most critical parts of the protein synthesis machine, which previously were 'untouchable,'" Alexander Mankin from University of Illinois at Chicago noted.
The study claimed no one has ever developed something of this nature and that the human-made ribosome may be able to be manipulated in the laboratory to do things natural ribosomes cannot do.
The findings were detailed in the journal Nature.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
